Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. boosted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 90.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,001 shares of the medical instruments supplier's stock after acquiring an additional 6,643 shares during the period. Victory Capital Management Inc. owned about 0.26% of Mesa Laboratories worth $1,818,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Canada Pension Plan Investment Board acquired a new position in shares of Mesa Laboratories during the second quarter worth about $26,000. Berry Wealth Group LP acquired a new stake in shares of Mesa Laboratories in the third quarter worth $204,000. Amalgamated Bank increased its position in shares of Mesa Laboratories by 6.5% in the third quarter. Amalgamated Bank now owns 1,588 shares of the medical instruments supplier's stock worth $206,000 after acquiring an additional 97 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in shares of Mesa Laboratories in the second quarter worth $183,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Mesa Laboratories in the third quarter worth $302,000. 90.60% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MLAB. Evercore ISI raised their price target on shares of Mesa Laboratories from $120.00 to $160.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Wells Fargo & Company began coverage on shares of Mesa Laboratories in a report on Tuesday, August 27th. They set an "underweight" rating and a $120.00 price target for the company. Finally, StockNews.com lowered shares of Mesa Laboratories from a "buy" rating to a "hold" rating in a report on Wednesday, November 13th.

Mesa Laboratories Stock Up 4.1 %

NASDAQ MLAB traded up $4.49 during trading hours on Monday, reaching $113.58. 20,629 shares of the company traded hands, compared to its average volume of 41,401. Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $141.17. The company has a current ratio of 0.70, a quick ratio of 0.51 and a debt-to-equity ratio of 0.65. The company has a 50 day moving average of $121.31 and a two-hundred day moving average of $114.52.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 29th will be given a $0.16 dividend. The ex-dividend date is Friday, November 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.56%. Mesa Laboratories's payout ratio is currently -1.40%.

Insider Transactions at Mesa Laboratories

In related news, CEO Gary M. Owens sold 2,518 shares of Mesa Laboratories stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $113.62, for a total value of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares in the company, valued at $5,213,794.56. This trade represents a 5.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Brian David Archbold sold 1,499 shares of Mesa Laboratories stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $125.00, for a total transaction of $187,375.00. The disclosure for this sale can be found here. Insiders own 4.40% of the company's stock.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.